Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Accenture
Boehringer Ingelheim
Citi
Moodys
McKesson
Fuji
Julphar
Medtronic

Generated: November 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208798

« Back to Dashboard

NDA 208798 describes ARMONAIR RESPICLICK, which is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug. Additional details are available on the ARMONAIR RESPICLICK profile page.

The generic ingredient in ARMONAIR RESPICLICK is fluticasone propionate. There are twenty-eight drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 208798
Tradename:ARMONAIR RESPICLICK
Applicant:Teva Pharm
Ingredient:fluticasone propionate
Patents:14
Formulation / Manufacturing:see details
Pharmacology for NDA: 208798
Suppliers and Packaging for NDA: 208798
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798 NDA Teva Respiratory, LLC 59310-705 59310-705-06 1 POUCH in 1 CARTON (59310-705-06) > 1 INHALER in 1 POUCH > 60 POWDER, METERED in 1 INHALER
ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798 NDA Teva Respiratory, LLC 59310-705 59310-705-08 1 POUCH in 1 CARTON (59310-705-08) > 1 INHALER in 1 POUCH > 60 POWDER, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INHALATIONStrength0.055MG/INH
Approval Date:Jan 27, 2017TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 27, 2020
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jun 23, 2021Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 208798

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-002 Jan 27, 2017 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-001 Jan 27, 2017 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharm ARMONAIR RESPICLICK fluticasone propionate POWDER;INHALATION 208798-003 Jan 27, 2017 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
QuintilesIMS
Medtronic
Chinese Patent Office
Citi
Boehringer Ingelheim
Fuji
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.